GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Trajan Group Holdings Ltd (ASX:TRJ) » Definitions » Research & Development

Trajan Group Holdings (ASX:TRJ) Research & Development : A$0.0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Trajan Group Holdings Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Trajan Group Holdings's Research & Development for the six months ended in Dec. 2024 was A$0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was A$0.0 Mil.

Trajan Group Holdings Research & Development Historical Data

The historical data trend for Trajan Group Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trajan Group Holdings Research & Development Chart

Trajan Group Holdings Annual Data
Trend Jun21 Jun22 Jun23 Jun24
Research & Development
- - - -

Trajan Group Holdings Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Research & Development Get a 7-Day Free Trial Premium Member Only - - - - -

Trajan Group Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Trajan Group Holdings  (ASX:TRJ) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Trajan Group Holdings Research & Development Related Terms

Thank you for viewing the detailed overview of Trajan Group Holdings's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Trajan Group Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Trajan Group Holdings Ltd (ASX:TRJ) » Definitions » Research & Development
Comparable Companies
ASX:AHC ASX:SDI ASX:OSX ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD TSE:4543 OCSE:COLO B XSWX:STMN XPAR:DIM BAX COO WST XTER:SRT HOLX SOLV ALGN
Traded in Other Exchanges
TRJNF:USA
Address
7 Argent Place, Ringwood, VIC, AUS, 3134
Website
https://www.trajanscimed.com
Trajan Group Holdings Ltd is a developer and manufacturer of analytical and life sciences products and devices, seeking to enrich human well-being through scientific measurement. Its current portfolio of products comprises products, devices and solutions that are used in the analysis of biological, food, and environmental sample. The Group now reports in three operating segments: Components and Consumables, Capital Equipment and Disruptive Technologies. Key revenue is generated from Components and Consumables that includes parts, supplies, components and consumable products across the world. The Group operates in Asia (Malaysia, Japan and Australia and New Zealand (ANZ)), USA and Europe, Middle East, Africa, and India (EMEA).

Trajan Group Holdings Headlines

No Headlines